Skip to main content
Premium Trial:

Request an Annual Quote

SBRI Enlists CombiMatrix s Array, RNA Tech for Infectious-Disease Research

NEW YORK, Oct. 9 (GenomeWeb News) - CombiMatrix will collaborate with researchers at the Seattle Biomedical Research Institute to study how the company's RNA technology and microarray platform may contribute to infectious disease research, the partners said today.

The agreement calls for SBRI scientists to use CombiMatrix's microarrays in their study of differential gene regulation of the Leishmania parasite lifecycle, the company said.

In addition, the school will use CombiMatrix's RNA technology to develop pools of RNAi compounds to silence multiple genes in Trypasonoma brucei, Trypanosoma cruzi, and Leishmania major.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.